Adult Giant Cell Glioblastoma Completed Phase 1 Trials for Temozolomide (DB00853)

IndicationStatusPhase
DBCOND0028733 (Adult Giant Cell Glioblastoma)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02337426Dimethyl Fumarate, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma MultiformeTreatment
NCT00049387Tipifarnib, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or GliosarcomaTreatment
NCT00316849Temsirolimus, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma MultiformeTreatment
NCT00650923Aflibercept, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed or Recurrent Glioblastoma Multiforme, Gliosarcoma, or Other Malignant GliomaTreatment
NCT01119599RO4929097, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Malignant GliomaTreatment
NCT02227901Tipifarnib, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma MultiformeTreatment